CompoAtlas

Gélules Liquides Sommeil+

Food supplement declared in France

Gélules Liquides Sommeil+ (Novaloa) is a food supplement declared in France. Status: retiré du marché le 13 August 2026. 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
Novaloa
Food business operator placing the product on the market
Nova CM Distribution
Status
Retiré du marché le 13 August 2026
Form
Capsule
Daily dose
1 gélule par jour, soit 0,58 g
Directions for use
Prendre une gélule par jour avant le coucher selon le besoin. DJA fixée à 1 gélule.
Intended populations
Population générale
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Prise concomittante d'alcool, Prise concomittante d'un contraceptif, Sous antidépresseurs, Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil

Declaration 362075, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Cannabis sativa L.GraineExtrait au CO2 supercritique50 mg
Cannabis sativa L.Graine (huile)Pression à froid2.6 mg
Lavandula angustifolia Mill.Sommités fleuriesDistillation1.9 mg
Cananga odorata (Lam.) Hook.f. & ThomsonFleurDistillation1.9 mg

Substances

NamePer day
mélatonine1 mg

Other ingredients

huile de noix de coco fractionnée

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Consommation interdite aux mineurs et aux femmes enceintes et / ou allaitantes. En cas de problème hépatique, consommation fortement déconseillée. Prises d’alcool et / ou de médicaments concomitants fortement déconseillées. Consulter un médecin en cas de doute.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • mélatonine
    Read the warning, when it applies and the studies cited

    MELATONIN - Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications for seizure, blood pressure, to suppress the immune system, to affect mental state or increase sedation, steroids or blood thinners (Wirtz et al. 2008; IOM 2004; Herxheimer and Petrie 2002; Lusardi et al. 2000; Maestroni 1993).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have cardiovascular, immune, liver or kidney disease, seizure disorder, asthma or diabetes (Peschke and Mühlbauer 2010; Carrillo-Vico et al. 2005; IOM 2004; der Marderosian and Beuttlers 2003; Sutherland et al. 2003; Calvo et al. 2002; Herxheimer and Petrie 2002; Sutherland et al. 2002; Cagnacci et al. 2001a; Arangino et al. 1999; Sheldon 1998; Maestroni 1993).

    12 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid taking with alcohol or products that cause drowsiness (Herxheimer and Petrie 2002; Holliman and Chyka 1997).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid driving or using machinery for 5 hours (Avery et al. 1998; Suhner et al. 1998b).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Buscemi et al. 2004; IOM 2004; Dipiro et al. 2002).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant or breastfeeding (IOM 2004).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if allergy occurs or if you experience headache, confusion, or nausea (Herxheimer and Petrie 2002).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

    MELATONIN - Sublingual

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications for seizure, blood pressure, to suppress the immune system, to affect mental state or increase sedation, steroids or blood thinners (Wirtz et al. 2008; IOM 2004; Herxheimer and Petrie 2002; Lusardi et al. 2000; Maestroni 1993).

    5 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a cardiovascular, immune, liver or kidney disease, seizure disorder, asthma or diabetes (Peschke and Mühlbauer 2010; Carrillo-Vico et al. 2005; IOM 2004; der Marderosian and Beuttlers 2003; Sutherland et al. 2003; Calvo et al. 2002; Herxheimer and Petrie 2002; Sutherland et al. 2002; Cagnacci et al. 2001a; Arangino et al. 1999; Sheldon 1998; Maestroni 1993).

    12 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid taking with alcohol or products that cause drowsiness (Herxheimer and Petrie 2002; Holliman and Chyka 1997).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid driving or using machinery for 5 hours (Avery et al. 1998; Suhner et al. 1998b).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if sleeplessness persists for more than 4 weeks (chronic insomnia) (Buscemi et al. 2004; IOM 2004; Dipiro et al. 2002).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant or breastfeeding (IOM 2004).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use if allergy occurs or if you experience headache, confusion, or nausea (Herxheimer and Petrie 2002).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Novaloa

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line